Ovarian Tissue Culture to Preserve Fertility in Transgender Male Patients after Hormonal Treatment

 

 Permissions and Reprints

Abstract

Objective To evaluate the reproductive and histological characteristics of fresh cultured ovarian tissue from transgender male patients.

Methods An in vitro pilot study in which samples were collected during sex reassignment surgery for transgender male patients. The ovarian cortex was cut into fragments of 2 mm, 3 mm, and 4 mm, and placed in a 96-well plate suitable for cultivation at days 0, 2, 4, 6, and 8, when the histology was analyzed.

Results Stromal hyperplasia was observed in all samples, and it was not associated with the obtainment of primordial or primary follicles. Peripheral reduction in cell count was also a recurrent finding. Primordial and primary follicles were identified with a heterogeneous pattern in fragments from the same patient and from different patients, and follicles in more advanced stages of development (secondary and antral) were not found. There was an association between the diameter of the ovarian fragments and the identification of primary follicles (p = 0.036). The number of days in culture was associated with histological signs of tissue damaging in the fragments (p = 0.002). The total number of follicles identified in the samples with 2 mm in diameter was significantly lower than in those that measured 4 mm in diameter (p = 0.031).

Conclusion A diameter of 4 mm is suitable for ovarian tissue culture with the benefit of ease of handling. Even after prolonged exposure to testosterone, the ovarian fragments presented primordial and primary follicles, maintaining viability throughout the days they were exposed to the culture. Freezing the ovarian cortex of transgender patients who will undergo surgery for gender reassignment would be an interesting option, in the future, for the preservation of fertility.

Resumo

Objetivo Avaliar as características reprodutivas e histológicas de tecido ovariano cultivado a fresco de pacientes transexuais masculinos.

Métodos Estudo experimental in vitro e piloto, no qual amostras foram coletadas durante a cirurgia de redesignação de sexo para pacientes transexuais masculinos. O córtex ovariano foi cortado em fragmentos de 2 mm, 3 mm, e 4 mm, e colocado em placa de 96 poços própria para cultivo nos dias 0, 2, 4, 6 e 8, quando a histologia foi analisada.

Resultados Hiperplasia estromal foi observada em todas as amostras, e não esteve associada à obtenção de folículos primordiais ou primários. A redução periférica no número de células também foi um achado recorrente. Folículos primordiais e primários foram identificados com padrão heterogêneo em fragmentos do mesmo paciente e em fragmentos de pacientes diferentes, não sendo encontrados folículos em estágios mais avançados de desenvolvimento (secundários e antrais). Houve associação entre o diâmetro dos fragmentos ovarianos e a identificação dos folículos primários (p = 0,036). O número de dias de cultura esteve associado a sinais histológicos de lesão tecidual nos fragmentos (p = 0,002). O número total de folículos identificados nas amostras de 2 mm de diâmetro foi significativamente menor do que nas de 4 mm de diâmetro (p = 0,031).

Conclusão O diâmetro de 4 mm parece ser mais adequado para a cultura de tecido ovariano com a vantagem de fácil manejo. Mesmo após exposição prolongada à testosterona, os fragmentos ovarianos apresentavam folículos primordiais e primários, e manteve a viabilidade ao longo dos dias de exposição à cultura. No futuro, o congelamento da cortical do ovário de pacientes transgêneros que se submeterão à cirurgia de redesignação sexual poderia ser uma opção interessante para a preservação da fertilidade.

Contributors

All authors were involved in the design and interpretation of the analyses, contributed to the writing of the manuscript, and read and approved the final manuscript.

Publication History

Received: 22 May 2021

Accepted: 11 November 2021

Article published online:
09 February 2022

© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• References

• 1 Overbeek A, van den Berg MH, van Leeuwen FE, Kaspers GJ, Lambalk CB, van Dulmen-den Broeder E. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: A systematic review. Cancer Treat Rev 2017; 53: 10-24 DOI: 10.1016/j.ctrv.2016.11.006.
  CrossrefPubMedGoogle Scholar
• 2 Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 1963; 158: 417-433 DOI: 10.1098/rspb.1963.0055.
  CrossrefPubMedGoogle Scholar
• 3 Bedoschi GM, Navarro PA, Oktay KH. Novel insights into the pathophysiology of chemotherapy-induced damage to the ovary. Panminerva Med 2019; 61 (01) 68-75 DOI: 10.23736/S0031-0808.18.03494-8.
  CrossrefPubMedGoogle Scholar
• 4 Sonigo C, Beau I, Grynberg M, Binart N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J 2019; 33 (01) 1278-1287 DOI: 10.1096/fj.201801089R.
  CrossrefPubMedGoogle Scholar
• 5 Roness H, Kashi O, Meirow D. Prevention of chemotherapy-induced ovarian damage. Fertil Steril 2016; 105 (01) 20-29 DOI: 10.1016/j.fertnstert.2015.11.043.
  CrossrefPubMedGoogle Scholar
• 6 Hussein RS, Khan Z, Zhao Y. Fertility preservation in women: indications and options for therapy. Mayo Clin Proc 2020; 95 (04) 770-783 DOI: 10.1016/j.mayocp.2019.10.009.
  CrossrefPubMedGoogle Scholar
• 7 Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K. et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update 2010; 16 (04) 395-414 DOI: 10.1093/humupd/dmp056.
  CrossrefPubMedGoogle Scholar
• 8 Van Den Broecke R, Van Der Elst J, Liu J, Hovatta O, Dhont M. The female-to-male transsexual patient: a source of human ovarian cortical tissue for experimental use. Hum Reprod 2001; 16 (01) 145-147 DOI: 10.1093/humrep/16.1.145.
  CrossrefPubMedGoogle Scholar
• 9 Smitz JE, Cortvrindt RG. In vitro growth and maturation of oocytes in human and non-human primates. Gynecol Obstet Invest 2004; 57 (01) 18-21
  PubMedGoogle Scholar
• 10 Schmidt KL, Byskov AG, Nyboe Andersen A, Müller J, Yding Andersen C. Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod 2003; 18 (06) 1158-1164 DOI: 10.1093/humrep/deg246.
  CrossrefPubMedGoogle Scholar
• 11 Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 2009; 6 (11) 638-647 DOI: 10.1038/nrclinonc.2009.146.
  CrossrefPubMedGoogle Scholar
• 12 Park M, Davidson R, Fox K. Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer. Semin Oncol 2006; 33 (06) 664-671 DOI: 10.1053/j.seminoncol.2006.08.015.
  CrossrefPubMedGoogle Scholar
• 13 Hao X, Anastácio A, Liu K, Rodriguez-Wallberg KA. Ovarian follicle depletion induced by chemotherapy and the investigational stages of potential fertility-protective treatments-a review. Int J Mol Sci 2019; 20 (19) 4720 DOI: 10.3390/ijms20194720.
  CrossrefPubMedGoogle Scholar
• 14 Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE. et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 2013; 14 (09) 873-881 DOI: 10.1016/S1470-2045(13)70251-1.
  CrossrefPubMedGoogle Scholar
• 15 Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J. et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism 2012; 13 (04) 165-232 DOI: 10.1080/15532739.2011.700873.
  CrossrefPubMedGoogle Scholar
• 16 Pache TD, Chadha S, Gooren LJ, Hop WC, Jaarsma KW, Dommerholt HB, Fauser BC. Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?. Histopathology 1991; 19 (05) 445-452 DOI: 10.1111/j.1365-2559.1991.tb00235.x.
  CrossrefPubMedGoogle Scholar
• 17 Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 1986; 62 (01) 16-21 DOI: 10.1210/jcem-62-1-16.
  CrossrefPubMedGoogle Scholar